YOU WONT BELIEVE: Clvr - What They Never Told You

Are Nasdaq-Traded Colombian Cannabis Stocks Worth Buying? Yes And No, Says Analyst

Cantor Fitzgerald's analyst Pablo Zuanic initiated coverage on two cannabis companies on Monday: Flora Growth Corp. (NASDAQ: FLGC) and Clever Leaves Holdings Inc (NASDAQ: CLVR)

Benzinga · Aug 1, 2022

3 Cannabis Stocks That Have Plunged More Than 55% in 2022

The outlook for the cannabis industry is brightening due to the overwhelming demand for it to treat several diseases. However, the uncertainty surrounding the legalization of cannabis at the federal level, and renewed concerns related to the health implications of its use, have caused many companies to suffer a retreat.…

StockNews.com · May 20, 2022

Clever Leaves Reports First Quarter 2022 Results: Revenue Increases 50% To $5.2M

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and operating results for the first quarter en

Benzinga · May 13, 2022

A Preview Of Clever Leaves Holdings's Earnings

Clever Leaves Holdings (NASDAQ:CLVR) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts estimate that Clever Leaves Holdings will report an earnings per share (EPS) of $-0.53.

Benzinga · Mar 23, 2022

Clever Leaves Teams Up With FoliuMed To Import Colombian Cannabis EU-GMP Bulk Extracts Into Germany

Clever Leaves Holdings Inc. (NASDAQ: CLVR) has signed a one-year international sales agreement with German- Colombian operator FoliuMed Holdings and its German manufacturing partner, Fidelio Healthcare. With access to three of Clever Leaves’ pharmaceutical grade bulk cannabis extracts

Benzinga · Mar 2, 2022

Clever Leaves Inks $7.8M Product Deal With Australian Medical Cannabis Company

Clever Leaves Holdings Inc. (NASDAQ: CLVR) has inked a four-year take or pay supply agreement with an Australian medicinal cannabis company, Australian Natural Therapeutics Group.

Benzinga · Feb 28, 2022

Clever Leaves Expands Partnership With German Cannabis Distributor Cansativa On Heels Of $15M Raise

Clever Leaves Holdings Inc. (NASDAQ: CLVR) is expanding its partnership with German cannabis distributor and wholesaler Cansativa GmbH.

Benzinga · Feb 22, 2022

Clever Leaves' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership

Pharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: CLVR) will soon be available for distribution by its partner in Germany, Ethypharm GmbH, a European specialty pharmaceutical company.

Benzinga · Feb 17, 2022

Clever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC Flower

Clever Leaves Holdings Inc. (NASDAQ: CLVR) announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. by signing a two-year, take-or-pay basis supply agreement.

Benzinga · Feb 14, 2022

Clever Leaves' Q4 Revenue Up 25% YoY, Introduces 2022 Outlook & New CEO

Clever Leaves Holdings Inc. (NASDAQ: CLVR) reported its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021, along with its 2022 outlook.

Benzinga · Feb 9, 2022